DKCM
LBPH

Davidson Kempner Capital Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Davidson Kempner Capital Management’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25,000
Closed -$405K – 766
2021
Q1 		$405K Buy
+25,000
New +$409K ﹤0.01% 395

Other funds holding LBPH

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Davidson Kempner Capital Management's LBPH Position: Q2 2021 in Review

Davidson Kempner Capital Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q2 2021, closing a stake of 25,000 shares — an estimated $405K sold.

Davidson Kempner Capital Management first reported a position in LBPH in Q1 2021 and held it in 1 quarter. The position peaked at $405K in Q1 2021. 17 funds tracked by Wall St. Rank hold LBPH as of Q2 2021.

  • Davidson Kempner Capital Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 25,000 Longboard Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $405K.
  • Davidson Kempner Capital Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $405K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.